The entry of cloud technology in the software world has fundamentally changed how software is built, deployed, and scaled. Traditionally, applications were released only once or twice a year. Today, ...
As a potential biomarker of treatment response, ctDNA and utDNA analyses were performed before systemic therapy, at restaging, and for responders at the beginning of adjuvant nivolumab. ctDNA was ...
Discover the impact of digital pathology on drug discovery and biomarker research this International Women’s Day with Dr Amanda Hemmerich.
Electron movement and structures described in quantum physics allow researchers to better understand how and why materials like superconductors behave as they do. Rice University researchers Jianwei ...
A century after Robert Goddard’s first-ever launch of a liquid-fueled rocket, two NASA experts weigh in on what his legacy ...
Aible launches SafeClaw that enables long-running agents with built-in enterprise AI governance and guardrails.Aible ...
Asking a young child “what do you want to be when you grow up,” doesn’t often have much pressure. In fact, you can get some ...
When the last bedroom door closes, and the house finally goes quiet, many Gen X parents discover that the silence feels like ...
Enrollment spans Europe, the US, and Canada, targeting ~324 GA patients in a randomized, double-masked, sham-controlled phase 2 program. Dosing compares two intravitreal dose levels given every 12 or ...
AI-powered apps are driving higher conversions and revenue, but retention remains weak. High churn, shorter trials, and rising costs expose a gap between early excitement and lasting value.
GIP obesity drug enters Phase 3 with strong cash runway, but rising competition and trial risk. Click for this VKTX update.